Hyperglycemic memory in diabetic cardiomyopathy
- PMID: 34921674
- DOI: 10.1007/s11684-021-0881-2
Hyperglycemic memory in diabetic cardiomyopathy
Abstract
Cardiovascular diseases account for approximately 80% of deaths among individuals with diabetes mellitus, with diabetic cardiomyopathy as the major diabetic cardiovascular complication. Hyperglycemia is a symptom that abnormally activates multiple downstream pathways and contributes to cardiac hypertrophy, fibrosis, apoptosis, and other pathophysiological changes. Although glycemic control has long been at the center of diabetes therapy, multicenter randomized clinical studies have revealed that intensive glycemic control fails to reduce heart failure-associated hospitalization and mortality in patients with diabetes. This finding indicates that hyperglycemic stress persists in the cardiovascular system of patients with diabetes even if blood glucose level is tightly controlled to the normal level. This process is now referred to as hyperglycemic memory (HGM) phenomenon. We briefly reviewed herein the current advances that have been achieved in research on the underlying mechanisms of HGM in diabetic cardiomyopathy.
Keywords: diabetes; diabetic cardiomyopathy; hyperglycemic memory.
© 2021. The Author(s).
Similar articles
-
Subcellular mass spectrometric detection unveils hyperglycemic memory in the diabetic heart.J Diabetes. 2024 Nov;16(11):e70033. doi: 10.1111/1753-0407.70033. J Diabetes. 2024. PMID: 39539089 Free PMC article.
-
The role of hyperglycaemia in the development of diabetic cardiomyopathy.Arch Cardiovasc Dis. 2021 Nov;114(11):748-760. doi: 10.1016/j.acvd.2021.08.004. Epub 2021 Oct 6. Arch Cardiovasc Dis. 2021. PMID: 34627704 Review.
-
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues.Biomolecules. 2022 Feb 8;12(2):272. doi: 10.3390/biom12020272. Biomolecules. 2022. PMID: 35204778 Free PMC article. Review.
-
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.Acta Pharmacol Sin. 2019 Jan;40(1):1-8. doi: 10.1038/s41401-018-0042-6. Epub 2018 Jun 4. Acta Pharmacol Sin. 2019. PMID: 29867137 Free PMC article. Review.
-
The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.Int J Mol Sci. 2023 May 11;24(10):8604. doi: 10.3390/ijms24108604. Int J Mol Sci. 2023. PMID: 37239956 Free PMC article. Review.
Cited by
-
Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids.Front Cardiovasc Med. 2022 Aug 11;9:951597. doi: 10.3389/fcvm.2022.951597. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36035917 Free PMC article. Review.
-
Application of three-dimensional speckle tracking technique in measuring left ventricular myocardial function in patients with diabetes.World J Diabetes. 2024 Apr 15;15(4):783-792. doi: 10.4239/wjd.v15.i4.783. World J Diabetes. 2024. PMID: 38680686 Free PMC article.
-
Super-enhancer-driven LncRNA PPARα-seRNA exacerbates glucolipid metabolism and diabetic cardiomyopathy via recruiting KDM4B.Mol Metab. 2024 Aug;86:101978. doi: 10.1016/j.molmet.2024.101978. Epub 2024 Jun 29. Mol Metab. 2024. PMID: 38950776 Free PMC article.
-
Association between glycosylated hemoglobin levels, diabetes duration, and left ventricular diastolic dysfunction in patients with type 2 diabetes and preserved ejection fraction: a cross-sectional study.Front Endocrinol (Lausanne). 2023 Dec 20;14:1326891. doi: 10.3389/fendo.2023.1326891. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38174338 Free PMC article.
-
An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory.Mol Med. 2024 May 26;30(1):71. doi: 10.1186/s10020-024-00824-9. Mol Med. 2024. PMID: 38797859 Free PMC article. Review.
References
-
- Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 25(4): 543–567 - PubMed
-
- Farhangkhoee H, Khan ZA, Kaur H, Xin X, Chen S, Chakrabarti S. Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets. Pharmacol Ther 2006; 111(2): 384–399 - PubMed
-
- Fonarow GC. An approach to heart failure and diabetes mellitus. Am J Cardiol 2005; 96(4 Supplement): 47–52
-
- Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003; 108(13): 1541–1545 - PubMed
-
- Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, Dansky H, McClain DA, McIndoe R, Wassef MK, Rabadán-Diehl C, Goldberg IJ. Recipes for creating animal models of diabetic cardiovascular disease. Circ Res 2007; 100(10): 1415–1427 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical